XML 108 R43.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
The non-cash compensation expenses recognized in our consolidated statements of income for stock options, restricted stock units and under our employee stock purchase plan were as follows (in millions):
Year ended December 31,
202520242023
Classified as compensation and benefits expenses:
Stock options and RSUs
$223 $214 $201 
ESPP
15 14 13 
Capitalized as software development costs(26)(21)(18)
Total
$212 $207 $196 
Classified as acquisition-related transaction and integration costs26 24 61 
Total non-cash compensation expense
$238 $231 $257 
Schedule of Stock Options
The following is a summary of our stock option activity:
Number of
Options
(in thousands)		Weighted
Average
Exercise Price per Option
Outstanding at January 1, 2023
2,787 $76.38 
Granted280 107.66 
Exercised(508)58.05 
Forfeited(20)114.19 
Outstanding at December 31, 2023
2,539 $83.20 
Granted212 135.46 
Exercised(561)61.21 
Outstanding at December 31, 2024
2,190 $93.90 
Granted— — 
Exercised(387)67.49 
Outstanding at December 31, 2025
1,803 $99.59 
Schedule of Stock Options Outstanding And Exercised Details of stock options outstanding as of December 31, 2025 are as follows:
Number of
Options
(in thousands)		Weighted
Average
Exercise Price		Weighted
Average
Remaining
Contractual Life
(Years)		Aggregate
Intrinsic
Value
(In millions)
Vested or expected to vest1,803$99.594.8$123
Exercisable1,571$95.894.4$113
Details of stock options exercised during 2025, 2024 and 2023 are as follows:
Year Ended December 31,
Options exercised:202520242023
Total intrinsic value of options exercised (in millions)
$41 $42$25
As of December 31,
Options outstanding:202520242023
Number of options exercisable (in thousands)1,571 1,715 2,000 
Weighted-average exercise price$95.89 $85.59 $74.49 
Schedule of Stock Options Valuation Assumptions During 2024 and 2023, we used the assumptions in the table below to compute the value:
Year Ended December 31,
Assumptions:20242023
Risk-free interest rate
4.14%3.47%
Expected life in years
6.06.1
Expected volatility
24%24%
Expected dividend yield
1.33%1.56%
Estimated weighted-average fair value of options granted per share
$37.56$27.39
Schedule of Nonvested Restricted Stock Options
The following is a summary of nonvested restricted shares under all plans discussed above:
Number of
Restricted
Stock Shares
(in thousands)		Weighted
Average
Grant-Date Fair
Value per Share
Nonvested at January 1, 2023
2,946$117.14 
Granted3,561110.96 
Vested(1,942)112.39 
Forfeited(269)114.88 
Nonvested at December 31, 2023
4,296$114.31 
Granted1,761136.03 
Vested(1,700)115.50 
Forfeited(258)120.94 
Nonvested at December 31, 2024
4,099$121.10 
Granted1,480167.54 
Vested(1,747)122.74 
Forfeited(170)138.08 
Nonvested at December 31, 2025
3,662$137.19 
Year Ended December 31,
202520242023
Time-based restricted stock units granted (in thousands)(1)
9221,0311,191
Total fair value of restricted stock vested under all restricted stock plans (in millions)
$289 $227 $150 
(1)    The remaining shares granted are performance-based.